BCTXZ

Conviction 37HealthcareScan · Mon, Aug 10, 2026

BCTXZ$0.0892+0.00%

ResistanceSupportVol 14

Vol MA14 375.95K

May 11May 28Jun 16Jul 6Jul 23Aug 10

BriaCell Therapeutics Corp.PHARMACEUTICAL PREPARATIONSwww.briacell.com ↗

Price0.0892

Change+0.00%

Gap+0.00%

Rel volume20.82×

Avg volume342.96K

Avg $ vol31.75K

SMA 200.0946

SMA 500.0886

SMA 2000.1454

Price vs 50+0.64%

Price vs 200-38.66%

MA stackmixed

50/200 cross—

Supertrendup · 0.0585

RSI (14)46

MACD hist-0.00

MACD cross—

Stoch %K / %D51 / 43

ADX (14)12

+DI / −DI17 / 16

RSI divergence—

MACD divergence—

ATR %+16.41%

ADR %15.62%

52w high0.4750

52w low0.0000

From 52w high-81.22%

Above 52w low—

New 52w highNo

SqueezeOn · 60d

Bollinger width28.16%

%B0.30

Donchian pos40.76%

Donchian high0.1174

Donchian low0.0698

AVWAP (52w high)0.1050

vs AVWAP high-15.03%

AVWAP (52w low)0.1122

vs AVWAP low-20.47%

OBV trendFlat

Chaikin MF (20)0.26

Today vs 20d20.82×

Avg vol (14d)375.95K

Avg vol (20d)342.96K

Avg $ vol (20d)31.75K

Market cap776.02K

RS 3m (vs SPY)-7.89%

RS 6m (vs SPY)-64.53%

RS line new highNo

Trend template1/8

Technical rank22.5

1 week-0.78%

1 month-10.71%

3 months-0.78%

6 months-49.03%

1 year-66.95%

YTD-63.59%

P/E-0.03

P/B-0.21

P/S—

P/FCF-0.03

EPS-62.19

Div yield—

ROE696.60%

ROA-97.19%

Debt/Eq—

Current7.07

EV/EBITDA0.22

Gross margin—

Net margin—

Rev growth—

EPS growth-449.14%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-6.1M

Revenue—

Net income-7.16M

Gross profit—

Free cash flow-28.63M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out2.33M

Employees4

ListedFri, Apr 25, 2025

Free float8.7M

Float %100.0%

Short interest20.18K

Days to cover0.1d

Short volume15.3%

Squeeze score16 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction37 / 100

Pattern quality—

Tech rank22.5 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.1137

Support0.0655

Days since event—

Candle confirm—

News sentiment—

Financials as of Thu, Apr 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in BCTXZ

All disclosures →

No recent disclosed trades by Congress in BCTXZ. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BCTXZ

No recent insider (Form 4) filings in BCTXZ. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in BCTXZ

EDGAR →

No recent SEC filings on file for BCTXZ.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.